Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Texas Tech Scientist Raises Concern of Using Beta Agonists in Beef Cattle

13.03.2014

The challenge is the drug aids efficiency but raises incidences of death.

Use of certain animal drugs known as beta agonists in cattle production has received considerable national attention.


Guy Loneragan

A Texas Tech University veterinary epidemiologist has found that although there are significant societal benefits to the practice, an increase in death loss of cattle raises questions about welfare implications of its use.

In a peer-reviewed article published today (March 12) in PLOS ONE, Guy Loneragan, professor of food safety and public health in Texas Tech’s College of Agricultural Sciences and Natural Resources, adds to this ongoing national dialogue.

... more about:
»Cattle »beef »drugs

“Beta agonists improve the efficiency of beef production and this improvement provides important societal benefits,” Loneragan said.

“The beta agonists approved by the U.S. Food and Drug Administration for use in cattle increase muscle growth and may reduce the amount of fat the cattle accumulates,” he said. “This means the cattle converts more of the feed it eats into beef, and it does this more efficiently.”

The article is co-authored by Daniel Thomson and Morgan Scott of Kansas State University and is titled “Increased mortality in groups of cattle administered the β-adrenergic agonists ractopamine hydrochloride and zilpaterol hydrochloride.” The manuscript is freely available at: http://dx.plos.org/10.1371/journal.pone.0091177.

With the use of beta agonists, cattle require less feed and less water to produce the same amount of beef than if no beta agonists were used. Less land would be used to grow the crops used to feed the animals and, therefore, less fuel to produce the same amount of beef. The improvement in the efficiency of production has meaningful societal benefits.

“However, through our extensive analysis, we found that the incidence of death among cattle administered beta agonists was 75 to 90 percent greater than cattle not administered the beta agonists,” Loneragan said. “This increase in death loss raises critical animal-welfare questions. We believe an inclusive dialogue is needed to explore the use of animal drugs solely to improve performance, yet have no offsetting health benefits for the animals to which they are administered. This is particularly needed for those drugs that appear to adversely impact animal welfare, such as beta agonists.”

At a recent symposium held at Texas Tech, the world renowned animal behaviorist and welfare expert Temple Grandin headlined a discussion of beta agonists and animal welfare.

In a recent joint NPR interview with Loneragan and Grandin about beta agonists’ affect on animal welfare, Grandin said, “These problems have got to stop. I’ve laid awake at night about it. I’ve worked all my career to improve how animals are handled and these animals are just suffering. It has to stop.”

Grandin generally speaks on issues at the slaughter houses with lame cattle due to beta agonists, whereas Loneragan’s work covers beta agonists in feedlots, which is the topic of the newly published paper.

“To paraphrase Dr. Grandin, we owe the animals we raise for food a decent life and a decent death,” Loneragan said. “We certainly need to better understand the manner in which animals fed beta agonist die at the feedlot and work out how to balance the societal benefits of beta agonist use with societal expectations concerning the welfare of animals raised for food.”

Find Texas Tech news, experts and story ideas at Texas Tech Today Media Resources or follow us on Twitter.

CONTACT: Guy Loneragan, professor, Department of Animal and Food Sciences,(806) 834-1291 or guy.loneragan@ttu.edu.

Leslie Cranford | newswise
Further information:
http://www.ttu.edu

Further reports about: Cattle beef drugs

More articles from Agricultural and Forestry Science:

nachricht Alkaline soil, sensible sensor
03.08.2017 | American Society of Agronomy

nachricht New 3-D model predicts best planting practices for farmers
26.06.2017 | Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign

All articles from Agricultural and Forestry Science >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Cholesterol-lowering drugs may fight infectious disease

22.08.2017 | Health and Medicine

Meter-sized single-crystal graphene growth becomes possible

22.08.2017 | Materials Sciences

Repairing damaged hearts with self-healing heart cells

22.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>